Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men

Objective: Salt-induced elevation of the endogenous digitalis like sodium pump ligand marinobufagenin (MBG) in the Dahl salt-sensitive rats resulted in elevated blood pressure (BP). Here, we tested, in humans, whether MBG levels are related to ambulatory 24-h BP (ABP), controlled long-term increase of salt-intake induces changes in MBG and any salt-induced change in MBG is related to salt sensitivity. Methods: Thirty-nine healthy individuals (53 ± 11 years old; 20 men and 19 women) had a total daily NaCl intake of 50 mmol (low-salt) and 150 mmol (high-salt) for 4 weeks each, in a random order. ABP and MBG in plasma and urine were measured at baseline (unstandardized salt intake) and after high and low-salt intake. Results: At baseline, plasma MBG (P-MBG) was related to 24-h SBP (r = 0.43, P = 0.007) and DBP (r = 0.32, P = 0.047), whereas 24-h urinary excretion of MBG (UE-MBG) was related to 24-h DBP only (r = 0.42, P = 0.008). Sex-specific analyses revealed that these relationships were significant in men only. Compared with low-salt, high-salt diet increased P-MBG (P = 0.029), mainly driven by results in men. Male P-MBG responders vs. nonresponders (above vs. below median of high-salt induced P-MBG increase) had markedly enhanced SBP (10.4 ± 6.4 vs. 1.0 ± 6.0 mmHg; P = 0.003) and DBP (6.7 ± 5.0 vs. −0.6 ± 3.6 mmHg; P = 0.001) salt sensitivity. Conclusion: In men, MBG increases with 24-h ABP, and similar to Dahl salt-sensitive rats, 4 weeks of high-salt induced MBG response is accompanied by marked salt sensitivity. However, these patterns seem to be sex-specific and are not observed in women.

[1]  W. März,et al.  Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications , 2015, Clinical and experimental hypertension.

[2]  Bradley S. Fleenor,et al.  Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[3]  J. Shapiro,et al.  Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets , 2009, Pharmacological Reviews.

[4]  David E. Anderson,et al.  Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  A. Askari,et al.  Progesterone binding to the α1-subunit of the Na/K-ATPase on the cell surface: Insights from computational modeling , 2008, Steroids.

[6]  O. Melander,et al.  Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma , 2007, Journal of hypertension.

[7]  E. Lakatta,et al.  Endogenous Ligand of &agr;1 Sodium Pump, Marinobufagenin, Is a Novel Mediator of Sodium Chloride–Dependent Hypertension , 2002, Circulation.

[8]  E. Lakatta,et al.  Phorbol Diacetate Potentiates Na+-K+ ATPase Inhibition by a Putative Endogenous Ligand, Marinobufagenin , 2002, Hypertension.

[9]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[10]  E. Lakatta,et al.  Endogenous Na,K Pump Ligands Are Differentially Regulated During Acute NaCl Loading of Dahl Rats , 2000, Circulation.

[11]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[12]  O. Fedorova,et al.  Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. , 1999, Journal of hypertension.

[13]  N. Schork,et al.  The alpha1 Na,K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitiveHSD rat. , 1998, The Journal of clinical investigation.

[14]  N. Vaziri,et al.  Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. , 1998, Clinical and experimental hypertension.

[15]  W. Howald,et al.  Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. , 1998, Hypertension.

[16]  O. Fedorova,et al.  Inhibition of Na/K ATPase From Rat Aorta by Two Na/K Pump Inhibitors, Ouabain and Marinobufagenin: Evidence of Interaction With Different α-Subunit Isoforms , 1997 .

[17]  O. Fedorova,et al.  Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. , 1997, American journal of hypertension.

[18]  A. Logan,et al.  Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.

[19]  U. Hopfer,et al.  Pathophysiological consequences of changes in the coupling ratio of Na,K-ATPase for renal sodium reabsorption and its implications for hypertension. , 1996, Hypertension.

[20]  A. Seguro,et al.  Effect of low and high potassium diets on H(+)-K(+)-ATPase and Na(+)-K(+)-ATPase activities in the rat inner medullary collecting duct cells. , 1994, Renal physiology and biochemistry.

[21]  S. Mujais,et al.  Regulation of the renal Na:K pump: role of progesterone. , 1993, Journal of the American Society of Nephrology : JASN.

[22]  Y. Yamori,et al.  POTASSIUM ACCELERATES URINARY SODIUM EXCRETION DURING SALT LOADING WITHOUT STIMULATING ATRIAL NATRIURETIC POLYPEPTIDE SECRETION , 1992, Clinical and experimental pharmacology & physiology.

[23]  L. Svetkey,et al.  Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. , 1992, Journal of the American Society of Nephrology : JASN.

[24]  N. Fineberg,et al.  Sodium and Volume Sensitivity of Blood Pressure Age and Pressure Change Over Time , 1991, Hypertension.

[25]  M. A. Clark,et al.  Purification of an Endogenous Digitalislike Factor From Human Plasma for Structural Analysis , 1991, Hypertension.

[26]  N. Fineberg,et al.  Definitions and Characteristics of Sodium Sensitivity and Blood Pressure Resistance , 1986, Hypertension.

[27]  N. Markandu,et al.  MODERATE POTASSIUM SUPPLEMENTATION IN ESSENTIAL HYPERTENSION , 1982, The Lancet.

[28]  M. Blaustein Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. , 1977, The American journal of physiology.

[29]  H. W. Overbeck,et al.  The role of humoral agents in volume expanded hypertension. , 1976, Life sciences.

[30]  J. Iwai,et al.  Humoral transmission of hypertension: evidence from parabiosis. , 1969, Circulation research.

[31]  Cole Lb,et al.  An attack of tetanus. , 1968 .